Financing driven by existing investor Negev and Filament's Board of Directors Company also announces intention to voluntarily delist from Cboe Canada VANCOUVER, BC , April 3, 2025 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) (FSE: 7QS) (" Filament " or the " Company "), a clinical‐stage natural psychedelic drug development company, today announces a financing led by Negev Capital Fund One, LP (" Negev "), a... Read More